Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Glaxo Wellcome |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00001990 |
To facilitate provision of atovaquone (566C80) to patients who have severe Pneumocystis carinii pneumonia (PCP) and are intolerant and/or unresponsive to trimethoprim / sulfamethoxazole ( TMX / SMX ); to monitor serious adverse events attributable to 566C80.
Condition | Intervention |
---|---|
Pneumonia, Pneumocystis Carinii HIV Infections |
Drug: Atovaquone |
Study Type: | Interventional |
Study Design: | Treatment, Open Label |
Official Title: | An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have the following:
Exclusion Criteria
Co-existing Condition:
Excluded:
Required:
Study ID Numbers: | 053D, 33384-10 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00001990 |
Health Authority: | United States: Food and Drug Administration |
Trimethoprim-Sulfamethoxazole Combination Pneumonia, Pneumocystis carinii Pentamidine |
Antifungal Agents Acquired Immunodeficiency Syndrome atovaquone |
Trimethoprim Sexually Transmitted Diseases, Viral Sulfamethoxazole Clotrimazole Miconazole Acquired Immunodeficiency Syndrome Tioconazole Trimethoprim-Sulfamethoxazole Combination Immunologic Deficiency Syndromes Folic Acid Virus Diseases Mycoses |
Pneumonia, Pneumocystis Atovaquone Pneumocystis Infections Respiratory Tract Diseases Respiratory Tract Infections HIV Infections Lung Diseases Sexually Transmitted Diseases Pentamidine Retroviridae Infections Pneumonia Lung Diseases, Fungal |
Anti-Infective Agents Trypanocidal Agents RNA Virus Infections Antiprotozoal Agents Slow Virus Diseases Molecular Mechanisms of Pharmacological Action Immune System Diseases Enzyme Inhibitors Anti-Infective Agents, Urinary |
Folic Acid Antagonists Renal Agents Infection Pharmacologic Actions Antimalarials Antiparasitic Agents Antifungal Agents Therapeutic Uses Lentivirus Infections |